Home6541 • TPE
add
Tanvex Biopharma Inc
Previous close
$53.50
Day range
$53.50 - $54.70
Year range
$35.05 - $82.00
Market cap
13.00B TWD
Avg Volume
274.94K
P/E ratio
-
Dividend yield
-
Primary exchange
TPE
Market news
Financials
Income Statement
Revenue
Net income
| (TWD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 49.86M | 1,385.31% |
Operating expense | 374.32M | -11.44% |
Net income | -465.74M | -11.38% |
Net profit margin | -934.07 | 92.50% |
Earnings per share | — | — |
EBITDA | -299.34M | 24.71% |
Effective tax rate | 0.65% | — |
Balance Sheet
Total assets
Total liabilities
| (TWD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.08B | 179.62% |
Total assets | 7.65B | 176.79% |
Total liabilities | 2.10B | -10.79% |
Total equity | 5.55B | — |
Shares outstanding | 222.84M | — |
Price to book | 2.15 | — |
Return on assets | -19.07% | — |
Return on capital | -20.10% | — |
Cash Flow
Net change in cash
| (TWD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -465.74M | -11.38% |
Cash from operations | -288.81M | 1.92% |
Cash from investing | 1.00B | 2,915.32% |
Cash from financing | -15.94M | -104.77% |
Net change in cash | 700.23M | 15,512.64% |
Free cash flow | -145.20M | 21.07% |
About
Founded
2013
Website
Employees
133
